NightHawk Biosciences(NHWK) - 2024 Q4 - Annual Report

FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 For the transition period from ____________ to ____________ Commission file number: 001-35994 Scorpius Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 26-2844103 (Stat ...